|
Volumn 22, Issue 1, 2012, Pages 493-496
|
Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads
|
Author keywords
Backbone cyclization; Peptidomimetics; Rheumatoid arthritis
|
Indexed keywords
C(HS2 4);
C(HS4 4);
C(HS6 4);
CHYMOTRYPSIN;
CYCLOPEPTIDE;
EPITOPE;
NITRIC OXIDE;
TRYPSIN;
UNCLASSIFIED DRUG;
ARTICLE;
CIRCULAR DICHROISM;
CONFORMATIONAL TRANSITION;
CONTROLLED STUDY;
DRUG DESIGN;
ENZYME DEGRADATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN CELL;
RHEUMATOID ARTHRITIS;
ARTHRITIS, RHEUMATOID;
CHEMISTRY, PHARMACEUTICAL;
CIRCULAR DICHROISM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DESIGN;
EPITOPES;
HUMANS;
INFLAMMATION;
MODELS, CHEMICAL;
NITRIC OXIDE;
PEPTIDES;
PEPTIDES, CYCLIC;
PROTEIN STRUCTURE, SECONDARY;
PROTEIN STRUCTURE, TERTIARY;
TIME FACTORS;
|
EID: 84655161547
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.10.098 Document Type: Article |
Times cited : (18)
|
References (30)
|